Late Breaking Abstract - The TRITRIAL COPD study: preliminary baseline patient characteristics collected during the COVID-19 pandemic
P. Schino (Acquaviva delle Fonti (BA), Italy), E. Bargagli (Siena, Italy), A. Ricci (Rome, Italy), F. Marchesani (Macerata, Italy), A. Pennisi (Gravina di Catania (CT), Italy), A. Camiciottoli (Florence, Italy), A. Rocca (Bologna, Italy), M. D'Amato (Naples, Italy), F. Macagno (Rome, Italy), E. Ingrassia (Parma, Italy), U. Scaffidi Argentina (Parma, Italy), A. Piraino (Parma, Italy), L. Richeldi (Rome, Italy)
Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Schino (Acquaviva delle Fonti (BA), Italy), E. Bargagli (Siena, Italy), A. Ricci (Rome, Italy), F. Marchesani (Macerata, Italy), A. Pennisi (Gravina di Catania (CT), Italy), A. Camiciottoli (Florence, Italy), A. Rocca (Bologna, Italy), M. D'Amato (Naples, Italy), F. Macagno (Rome, Italy), E. Ingrassia (Parma, Italy), U. Scaffidi Argentina (Parma, Italy), A. Piraino (Parma, Italy), L. Richeldi (Rome, Italy). Late Breaking Abstract - The TRITRIAL COPD study: preliminary baseline patient characteristics collected during the COVID-19 pandemic. 2953
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: